194 related articles for article (PubMed ID: 20569473)
1. Generic and low dose antiretroviral therapy in adults and children: implication for scaling up treatment in resource limited settings.
Ramautarsing R; Ananworanich J
AIDS Res Ther; 2010 Jun; 7():18. PubMed ID: 20569473
[TBL] [Abstract][Full Text] [Related]
2. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Cvetkovic RS; Goa KL
Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Low dose versus high dose stavudine for treating people with HIV infection.
Magula N; Dedicoat M
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007497. PubMed ID: 25627012
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
6. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy.
O'Brien DP; Sauvageot D; Zachariah R; Humblet P;
AIDS; 2006 Oct; 20(15):1955-60. PubMed ID: 16988517
[TBL] [Abstract][Full Text] [Related]
7. ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.
Moore CL; Turkova A; Mujuru H; Kekitiinwa A; Lugemwa A; Kityo CM; Barlow-Mosha LN; Cressey TR; Violari A; Variava E; Cotton MF; Archary M; Compagnucci A; Puthanakit T; Behuhuma O; Saϊdi Y; Hakim J; Amuge P; Atwine L; Musiime V; Burger DM; Shakeshaft C; Giaquinto C; Rojo P; Gibb DM; Ford D;
BMC Infect Dis; 2021 Jan; 21(1):5. PubMed ID: 33446115
[TBL] [Abstract][Full Text] [Related]
8. When to start, what to start and other treatment controversies in pediatric HIV infection.
Turkova A; Webb RH; Lyall H
Paediatr Drugs; 2012 Dec; 14(6):361-76. PubMed ID: 23013459
[TBL] [Abstract][Full Text] [Related]
9. Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey.
Fortunak JM; de Souza RO; Kulkarni AA; King CL; Ellison T; Miranda LS
Antivir Ther; 2014; 19 Suppl 3(0 3):15-29. PubMed ID: 25310430
[TBL] [Abstract][Full Text] [Related]
10. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
11. The long-term effectiveness of generic adult fixed-dose combination antiretroviral therapy for HIV-infected Ugandan children.
Barlow-Mosha LN; Bagenda DS; Mudiope PK; Mubiru MC; Butler LM; Fowler MG; Musoke PM
Afr Health Sci; 2012 Sep; 12(3):249-58. PubMed ID: 23382737
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Piperaquine and Safety Profile of Dihydroartemisinin-Piperaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults.
Banda CG; Dzinjalamala F; Mukaka M; Mallewa J; Maiden V; Terlouw DJ; Lalloo DG; Khoo SH; Mwapasa V
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784846
[TBL] [Abstract][Full Text] [Related]
13. A comparison of different community models of antiretroviral therapy delivery with the standard of care among stable HIV+ patients: rationale and design of a non-inferiority cluster randomized trial, nested in the HPTN 071 (PopART) study.
Limbada M; Bwalya C; Macleod D; Floyd S; Schaap A; Situmbeko V; Hayes R; Fidler S; Ayles H;
Trials; 2021 Jan; 22(1):52. PubMed ID: 33430928
[TBL] [Abstract][Full Text] [Related]
14. Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.
Pai NP; Tulsky JP; Lawrence J; Colford JM; Reingold AL
Cochrane Database Syst Rev; 2005 Oct; (4):CD005482. PubMed ID: 16235406
[TBL] [Abstract][Full Text] [Related]
15. Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health.
Beck EJ; Passarelli C; Lui I; Guichard AC; Simao M; De Lay P; Loures L
Antivir Ther; 2014; 19 Suppl 3():117-23. PubMed ID: 25310477
[TBL] [Abstract][Full Text] [Related]
16. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.
Haberer JE; Sabin L; Amico KR; Orrell C; Galárraga O; Tsai AC; Vreeman RC; Wilson I; Sam-Agudu NA; Blaschke TF; Vrijens B; Mellins CA; Remien RH; Weiser SD; Lowenthal E; Stirratt MJ; Sow PS; Thomas B; Ford N; Mills E; Lester R; Nachega JB; Bwana BM; Ssewamala F; Mbuagbaw L; Munderi P; Geng E; Bangsberg DR
J Int AIDS Soc; 2017; 20(1):21371. PubMed ID: 28630651
[No Abstract] [Full Text] [Related]
17. Trends and economic stress: a challenge to universal access to antiretroviral treatment in India.
Dhamija P; Bansal D; Medhi B
Curr HIV Res; 2009 Jul; 7(4):410-7. PubMed ID: 19601776
[TBL] [Abstract][Full Text] [Related]
18. Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
Huang L; Carey V; Lindsey JC; Marzan F; Gingrich D; Graham B; Barlow-Mosha L; Ssemambo PK; Kamthunzi P; Nachman S; Parikh S; Aweeka FT;
PLoS One; 2017; 12(10):e0186589. PubMed ID: 29065172
[TBL] [Abstract][Full Text] [Related]
19. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
Mbuagbaw L; Mursleen S; Irlam JH; Spaulding AB; Rutherford GW; Siegfried N
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004246. PubMed ID: 27943261
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis.
Lailulo Y; Kitenge M; Jaffer S; Aluko O; Nyasulu PS
Syst Rev; 2020 Dec; 9(1):292. PubMed ID: 33308294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
